Anti-Müllerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease


Saglam F., Onal E. D. , Ersoy R. , Koca C. , Ergin M., Erel O., ...Daha Fazla

Gynecological Endocrinology, cilt.31, ss.165-168, 2015 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 31 Konu: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3109/09513590.2014.973391
  • Dergi Adı: Gynecological Endocrinology
  • Sayfa Sayıları: ss.165-168

Özet

There is an increased incidence of autoimmune thyroid disease (AITD) in women with infertility. We hypothesized that serum anti-Mullerian hormone (AMH) levels will be lower in premenopausal women with AITD than controls. We evaluated ovarian reserve in women with AITD (n = 85) and healthy controls (n = 80), all <40 years old. Detailed data on reproductive history were obtained. Gonadotrophins, steroids, AMH, and inhibin B levels were measured during the follicular phase. The number of pregnancies as well as live births was lower in women with AITD (p < 0.01). No difference was observed in terms of FSH, estradiol, and inhibin B. AMH levels were lower in AITD women than in controls (1.16 + 0.17 versus 1.28 + 0.25 ng/ml, mean + SD, p = 0.001). According to the multiple regression analysis, even after age adjustment, AITD was significantly and independently affected AMH levels (t = 2.674, p = 0.008). Women with AITD seem to have a diminished ovarian follicular reserve and measurement of serum AMH level has the potential to be used to predict this comorbidity.